Hutchmed (HCM) reported H1 earnings Thursday of $2.61 per American depositary share, up from $0.15 a year earlier.
Total revenue for the six months ended June 30 was $277.7 million, compared with $305.7 million a year earlier.
As of June 30, the company said it had $1.36 billion in cash and cash equivalents and short-term investments compared with $836.1 million as of Dec. 31.
The company's shares were down 3.3% in recent premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。